The Weill Cornell Medicine Comprehensive Thalassemia Center staff members are committed to the safety and well-being of our patients. For more information about COVID-19, here are links to other sources: the Weill Cornell COVID-19 patient guide, the Centers for Disease Control (CDC) website, the NYC Department of Health website, and the Cooley's Anemia Foundation website. These sources provide up-to-date information on signs and symptoms, precautions to take, when to quarantine and other important tips. If you have developed a fever, cough, shortness of breath or other respiratory symptoms, please call your provider right away.
New York Comprehensive Thalassemia Center

For Patients

Our Program

Our clinical thalassemia program consists of a pediatric unit and an adult unit, with a seamless transition program connecting the two. Each unit has a dedicated physician, and the program is supported by a practitioner who bridges the two units. Transfusions are administered in state-of-the-art outpatient pediatric and adult infusion centers, supported by NewYork-Presbyterian/Weill Cornell Medicine blood bank and laboratory facilities.

Open Clinical Trials

Weill Cornell Thalassemia Clinical Trials


We are committed to advancing thalassemia patient care and facilitating the development of novel treatments through research studies and clinical trials. The development of new strategies, including disease-modifying and curative therapies, form the basis of our progressive approach to thalassemia management for patients at Weill Cornell Medicine.

New York Comprehensive Thalassemia Center of Weill Cornell Medicine 525 E. 68th St.
Payson 695
New York, NY 10065 Phone: (212) 746-3400